You are herePharma News

Pharma News

Gut bacteria signal to brain when you are full

The bacteria in your gut may help control when and how much you eat as researchers have found that 20 minutes after a meal they produce proteins that influence activation of appetite-regulating neurons in the brain.

Novartis' Cosentyx receives European nod to treat ankylosing spondylitis & psoriatic arthritis

The European Commission (EC) has approved Novartis' Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumour necrosis factor (anti-TNF) therapy.

Pfizer, IIT-Delhi collaborate for healthcare incubation

Pfizer and IIT-Delhi on Tuesday said they have launched an incubation accelerator initiative at the later's campus for Indian startup companies as well as individuals.

FDA approves Opdivo to treat advanced form of kidney cancer

The U.S. Food and Drug Administration  approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

European Commission approves Kyprolis for combination use in patients with relapsed multiple myeloma

Amgen announced the European Commission (EC) granted marketing authorization for Kyprolis® (carfilzomib) in combination with lenalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. Kyprolis is the first irreversible proteasome inhibitor approved in the European Union (EU) for use in combination treatment of patients with relapsed multiple myeloma

AstraZeneca inks 3 technology partnerships to strengthen its Cambridge lead discovery centre

AstraZeneca, a global, innovation-driven biopharmaceutical business, announced three new partnerships that will deliver industry-leading technologies to drive the AstraZeneca MRC UK Centre for Lead Discovery in the search for novel small molecule medicines. The partnerships will ensure state-of-the-art screening and compound management at the facility, which will be located within the company’s new global R&D centre at the Cambridge Biomedical Campus. It will screen around 2 million chemical structures per target to find new compounds for disease targets.

Unending tests of Maggi cannot go on: Apex consumer court (Lead)

Following the Rs.640-crore class action suit filed by the government against Nestle India, the apex consumer court on Tuesday said "unending testing of Maggi samples cannot go on".

China's plastic surgery industry set to become world's third largest

China's plastic surgery industry is set to become the world's third largest by the end of this year with a valuation of 400 billion yuan ($62.6 billion) and is expected to double in size by 2019.

Vitamin D doesn't cut cold in asthma patients

Taking vitamin D supplements does not reduce the number or severity of cold in asthma patients, suggests new research.

Daily antibiotics may prevent drug-resistant TB

Prescribing antibiotic doses once or twice a week for tuberculosis (TB) treatment are more likely to lead to drug resistant strains than daily antibiotic regimens, new research has found.